CIK 0000886744
- Large accelerated filer
GERON CORP
Sign in to watch- Ticker
- GERN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752287752
- Phone
- +1 650-473-7700
- Business address
- 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
- Former names
- GERON CORPORATION
- Open-market buys, last 90 days
- $62,105
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$62,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-30 | Kapur Anil EVP, Corp Strategy & CCO | Grant or award | +13,062 | $1.11 | $14K | 47,195 |
| 2022-06-30 | Spiegel Robert J. Director | Grant or award | +4,637 | 145,652 | ||
| 2022-05-10 | Spiegel Robert J. Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2022-05-10 | O'Farrell Elizabeth G. Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2022-05-10 | Molineaux Susan Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2022-05-10 | LAWLIS V BRYAN Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2022-05-10 | EASTHAM KARIN Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2022-05-10 | Bir Dawn Carter Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2022-04-20 | EASTHAM KARIN Director | Option exercise | +35,000 | $1.41 | $49K | 74,047 |
| 2022-04-20 | EASTHAM KARIN Director | Option exercise · Stock Option (right to buy) | −35,000 | 0 | ||
| 2022-03-31 | Spiegel Robert J. Director | Grant or award | +5,284 | 141,015 | ||
| 2022-02-16 | ROSENFIELD STEPHEN EVP, Chief Legal Off & Sec | Grant or award · Employee Stock Option (right to buy) | +750,000 | 750,000 | ||
| 2022-02-16 | Bloom Olivia Kyusuk EVP, Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +750,000 | 750,000 | ||
| 2022-02-16 | GRETHLEIN ANDREW J EVP, Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +750,000 | 750,000 | ||
| 2022-02-16 | Kapur Anil EVP, Corp Strategy & CCO | Grant or award · Employee Stock Option (right to buy) | +750,000 | 750,000 | ||
| 2022-02-16 | Rizo Aleksandra EVP, Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +750,000 | 750,000 | ||
| 2022-02-16 | SCARLETT JOHN A Chairman, President and CEO | Grant or award · Employee Stock Option (Right to buy) | +2,100,000 | 2,100,000 | ||
| 2021-12-31 | Spiegel Robert J. Director | Grant or award | +5,891 | 135,731 | ||
| 2021-09-30 | Spiegel Robert J. Director | Grant or award | +5,246 | 129,840 | ||
| 2021-06-30 | Spiegel Robert J. Director | Grant or award | +5,097 | 124,594 |
Page 9 of 15 · 291 trades